 |
10 Depression in the Elderly
10.1 Introduction to Depression in the Elderly by Professor Edmond Chiu
References
Regier DA, Farmer ME, Rae DS, et al. One-month prevalence of mental disorders in the United States and sociodemographic characteristics: the Epidemiologic Catchment Area study. Acta Psychiatrica Scandinavica 1993;88:35-47.
Helmchen H, Linden M, Wernicke T. Psychiatric morbidity in the oldest old. Results of the Berlin Ageing Study. Nervenarzt 1996;67(9):739-50.
Ames D. Depressive disorders among elderly people in long-term institutional care. Australian and New Zealand Journal of Psychiatry 1993;27(3):379-91.
Koenig H, Meador K, Shelp F, Goli V, Cohen H, Blazer D. Major depressive disorder in hospitalized medically ill patients: an examination of young and elderly male veterans. Journal of the American Geriatric Society 1991;39(9):881-90.
Gurland B. The impact of depression on quality of life of the elderly. Clinical Geriatric Medicine 1992;8(2):377-86.
Murphy E. The prognosis of depression in old age. British Journal of Psychiatry 1983;142:111-119.
Greenwald B, Kramer-Ginsberg E, Krishnan K, Ashtari M, Aupperle P, Patel M. MRI signal hyperintensities in geriatric depression. American Journal of Psychiatry 1996;153:1212-1215.
Roth M, Mountjoy CQ, Amrein R. Moclobemide in elderly patients with cognitive decline and depression. An international double-blind, placebo-controlled study. British Journal of Psychiatry 1996;168:149-157.
Koder D, Brodaty H, Anstey K. Cognitive therapy for depression in the elderly. International Journal of Geriatric Psychiatry 1996;11:97-107.
Price TRP, McAllister TW. Safety and efficacy of ECT in depressed patients with dementia: A review of clinical experience. Convulsive Therapy 1989;5:61-74.
Group OADI. How long should the elderly take antidepressants? A double-blind placebo-controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry 1993;162:175-182.
Reynolds-III C, Frank E, Perel J, et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. JAMA 1999;281(1):39-45.
Previous Section
Index
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
 |